Micardis better than benicar

Olmesartan medoxomil : a review of its use in the management of hypertension.Scott LJ, McCormack PL.
Wolters Kluwer Health | Adis, Auckland, New Zealand, an editorial office of Wolters Kluwer Health, Conshohocken, Pennsylvania, USA.

Olmesartan medoxomil (Olmetec((R)), Benicar((R))) is an angiotensin II type 1 (AT(1)) receptor antagonist (angiotensin receptor blocker [ARB]) that inhibits the actions of angiotensin II on the renin-angiotensin-aldosterone system, which plays a key role in the pathogenesis of hypertension. Oral olmesartan medoxomil 10-40 mg once daily is recommended for the treatment of adult patients with hypertension. In those with inadequate BP control using monotherapy, fixed-dose olmesartan medoxomil/hydrochlorothiazide (HCTZ) [Olmetec plus((R)), Benicar-HCT((R))] combination therapy may be initiated.Extensive clinical evidence from several large well designed trials and the clinical practice setting has confirmed the antihypertensive efficacy and good tolerability profile of oral olmesartan medoxomil, as monotherapy or in combination with HCTZ, in patients with hypertension, including elderly patients with isolated systolic hypertension (ISH). Notably, BP control is sustained throughout the 24-hour dosage interval, including during the last 4 hours of this period. In clinical trials, olmesartan medoxomil monotherapy provided better antihypertensive efficacy than losartan, candesartan cilexetil or irbesartan monotherapy, and was at least as effective as valsartan treatment, with a faster onset of action than other ARBs in terms of reductions from baseline in diastolic BP (DBP) and, in most instances, systolic BP (SBP). Combination therapy with olmesartan medoxomil plus HCTZ was superior to that with benazepril plus amlodipine, as effective as that with losartan plus HCTZ, noninferior to that with atenolol plus HCTZ, but less effective than that with telmisartan plus HCTZ, in individual trials. Data from ongoing clinical outcome trials are required to more fully determine the relative position of olmesartan medoxomil therapy in the management of hypertension. In the meantime, the consistent antihypertensive efficacy during the entire 24-hour dosage interval and good tolerability profile of olmesartan medoxomil, with or without HCTZ, make it a valuable option for the treatment of adult patients with hypertension, including the elderly.

Telmisartan always had an edge over olmesartan in terms of efficacy, i.e., 'power' and duration, but both are good drugs - probably the best two in class.

Viva Mi-car-dis!!! Wait, viva Tel-mis-ar-tan!!

Originally Posted by Anonymous

Telmisartan always had an edge over olmesartan in terms of efficacy, i.e., 'power' and duration, but both are good drugs - probably the best two in class.

You are crazy! Diovan is best in class. Look at scripts nationwide comparing our Micardis, Benicar, and Diovan. No compete! I would love to sell Diovan. The reps in my state are solid and have ins with many cardio groups.The only downfall to selling diovan compared to ours is they need to increase 3x the scripts we do to move their market share due to the massive volume diovan has. Ide love to sell it but I make more money selling Micardis due to the low volume.

Originally Posted by Anonymous

You are crazy! Diovan is best in class. Look at scripts nationwide comparing our Micardis, Benicar, and Diovan. No compete! I would love to sell Diovan. The reps in my state are solid and have ins with many cardio groups.The only downfall to selling diovan compared to ours is they need to increase 3x the scripts we do to move their market share due to the massive volume diovan has. Ide love to sell it but I make more money selling Micardis due to the low volume.

Diovan best in class??? Are you fucking high?

The only way that they can claim 'best' of anything is JUST marketshare. Go sell diovan you piece of shit. Oh and by the way, if they are getting paid on share, good luck to them. Diovan has been bleeding share since the begining of the year....no thanks to pussy-reps like you.

FYI...the diovan reps have 'ins' with the doctors NOT b/c of the drug they sell....it is b/c they are better reps than you are. Hopefully they accidentally back into you when they leave the parking lot of the docs office next time you are there to sample-drop.

Friggin idiot.

Originally Posted by Anonymous

You are crazy! Diovan is best in class. Look at scripts nationwide comparing our Micardis, Benicar, and Diovan. No compete! I would love to sell Diovan. The reps in my state are solid and have ins with many cardio groups.The only downfall to selling diovan compared to ours is they need to increase 3x the scripts we do to move their market share due to the massive volume diovan has. Ide love to sell it but I make more money selling Micardis due to the low volume.

AGREED you must not be able to sell shit, go sell Diovan then, we don't need you here. By the way the only reason they have relationships is because they bought them. Period.

Hey shit-for-brains, why in the world would you think Diovan is better than Micardis. We have favorable head-to-head data. You work for B/I? Get with the damn program or move on.

Really dipshit! Keep that stuff quiet. Would not want the feds checking it out. What a f-ing idiot.

Not to mention the shaddy fuckers at Novartis pays every big Dr. in territory.

Rukidding, I would love to have the marketing they used @ D-Sankyo, IT WORKED. The EMP is so old along with Steve Martins blue veins. Going from boxes to bottles did not hurt & they did what we couldnt on S-Programs, shady or not Im jealous.

If you're that easily impressed, go join 'em.

Their internal climate survey results were published last month. It was stellar. Excellent management and a great place to work.

Yipee

Well after all the bashing y'all did I still don't know if Benicar is better than Micardis. What I do know is I have been taking Benicar for 5 years, I have no insurance and at the moment out of work. Benicar costs me $83.00 per month plus the water pill needed. I have a card for one year prescription for Micardis at no charge. Can anyone without a potty mouth tell me if they are equal? Thank you

Benicar is better. If my pressure was uncontrolled, I would pick Benicar.

Originally Posted by Anonymous

Well after all the bashing y'all did I still don't know if Benicar is better than Micardis. What I do know is I have been taking Benicar for 5 years, I have no insurance and at the moment out of work. Benicar costs me $83.00 per month plus the water pill needed. I have a card for one year prescription for Micardis at no charge. Can anyone without a potty mouth tell me if they are equal? Thank you

A suggestion would be to pick a drug that outperforms Placebo in the prevention of stroke. This is the wonder drug that does nothing its reps claims to do.

The behavior by this company has been criminal for years.

Originally Posted by Anonymous

A suggestion would be to pick a drug that outperforms Placebo in the prevention of stroke. This is the wonder drug that does nothing its reps claims to do.

The behavior by this company has been criminal for years.

And hiring you was criminal act #1?

Originally Posted by Anonymous

Telmisartan always had an edge over olmesartan in terms of efficacy, i.e., 'power' and duration, but both are good drugs - probably the best two in class.

Very true. The difference is Benicar is actually sold! As a group, we at BI could not get 50% market share with the cure for cancer!